» Articles » PMID: 7812619

Antagonism by Riluzole of Entry of Calcium Evoked by NMDA and Veratridine in Rat Cultured Granule Cells: Evidence for a Dual Mechanism of Action

Overview
Journal Br J Pharmacol
Publisher Wiley
Specialty Pharmacology
Date 1994 Sep 1
PMID 7812619
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

1. Intracellular calcium levels were measured in cultured cerebellar granule cells of the rat by use of the fluorescent dye, indo-1/AM. 2. Intracellular calcium levels were increased by depolarizing stimuli such as N-methyl-D-aspartate (NMDA) (100 microM), glutamic acid (20 microM), and veratridine (10 microM). This increase was essentially due to entry of external calcium. 3. Riluzole (10 microM) blocked responses to all the depolarizing agents. 4. Riluzole could still block the increase in intracellular calcium evoked by NMDA or glutamic acid when sodium channels were blocked by tetrodotoxin, suggesting that this effect is not mediated by a direct action of riluzole on the voltage-dependent sodium channel. 5. Pretreatment of the cells with pertussis toxin (0.1 micrograms ml-1) did not modify the increases in intracellular calcium evoked by NMDA, glutamic acid or veratridine. 6. In pertussis toxin-treated cells, riluzole could no longer block responses to excitatory amino acids, but still blocked responses to veratridine. 7. It is concluded that riluzole has a dual action on cerebellar granule cells, both blocking voltage-dependent sodium channels and interfering with NMDA receptor-mediated responses via a pertussis toxin-sensitive mechanism. Furthermore, these two processes have been shown to be independent.

Citing Articles

Targeting -Methyl-d-Aspartate Receptors in Neurodegenerative Diseases.

Carles A, Freyssin A, Perin-Dureau F, Rubinstenn G, Maurice T Int J Mol Sci. 2024; 25(7).

PMID: 38612544 PMC: 11011887. DOI: 10.3390/ijms25073733.


The multifaceted functions of β-arrestins and their therapeutic potential in neurodegenerative diseases.

Kee T, Khan S, Neidhart M, Masters B, Zhao V, Kim Y Exp Mol Med. 2024; 56(1):129-141.

PMID: 38212557 PMC: 10834518. DOI: 10.1038/s12276-023-01144-4.


Biomarkers and molecular mechanisms of Amyotrophic Lateral Sclerosis.

Chakraborty A, Diwan A AIMS Neurosci. 2023; 9(4):423-443.

PMID: 36660079 PMC: 9826749. DOI: 10.3934/Neuroscience.2022023.


Expanding the Toolbox: Novel Modulators of Endolysosomal Cation Channels.

Rautenberg S, Keller M, Leser C, Chen C, Bracher F, Grimm C Handb Exp Pharmacol. 2022; 278:249-276.

PMID: 35902436 DOI: 10.1007/164_2022_605.


Riluzole-induced apoptosis in osteosarcoma is mediated through Yes-associated protein upon phosphorylation by c-Abl Kinase.

Raghubir M, Azeem S, Hasnat R, Rahman C, Wong L, Yan S Sci Rep. 2021; 11(1):20974.

PMID: 34697383 PMC: 8546089. DOI: 10.1038/s41598-021-00439-8.


References
1.
Doble A, Hubert J, Blanchard J . Pertussis toxin pretreatment abolishes the inhibitory effect of riluzole and carbachol on D-[3H]aspartate release from cultured cerebellar granule cells. Neurosci Lett. 1992; 140(2):251-4. DOI: 10.1016/0304-3940(92)90114-m. View

2.
MIZOULE J, Meldrum B, Mazadier M, Croucher M, Ollat C, Uzan A . 2-Amino-6-trifluoromethoxy benzothiazole, a possible antagonist of excitatory amino acid neurotransmission--I. Anticonvulsant properties. Neuropharmacology. 1985; 24(8):767-73. DOI: 10.1016/0028-3908(85)90011-5. View

3.
Delumeau J, Tence M, Marin P, Cordier J, Glowinski J, Premont J . Synergistic Regulation of Cytosolic Ca2+ Concentration by Adenosine and alpha1-Adrenergic Agonists in Mouse Striatal Astrocytes. Eur J Neurosci. 1991; 3(6):539-550. DOI: 10.1111/j.1460-9568.1991.tb00841.x. View

4.
Mollard P, Guerineau N, Audin J, Dufy B . Measurement of CA2+ transients using simultaneous dual-emission microspectrofluorimetry and electrophysiology in individual pituitary cells. Biochem Biophys Res Commun. 1989; 164(3):1045-52. DOI: 10.1016/0006-291x(89)91775-0. View

5.
Benavides J, Camelin J, Mitrani N, Flamand F, Uzan A, Legrand J . 2-Amino-6-trifluoromethoxy benzothiazole, a possible antagonist of excitatory amino acid neurotransmission--II. Biochemical properties. Neuropharmacology. 1985; 24(11):1085-92. DOI: 10.1016/0028-3908(85)90196-0. View